Clinical pharmacist intervention to ensure safe stimulant prescribing practices at a Veterans Affairs facility

Clinical pharmacist intervention to ensure safe stimulant prescribing practices at a Veterans Affairs facility

Introduction The Psychotropic Drug Safety Initiative (PDSI) is a national Veterans Affairs program that recommends obtaining cardiovascular vital signs semiannually and urine toxicology screening annually for veterans prescribed stimulants. The PDSI also recommends a risk review of concurrent centra...

Full description

Bibliographic Details
Main Authors:	Bailey B. Bass, PharmD, BCPS, Lacey J. Vann, PharmD, BCPP
Format:	Article
Language:	English
Published:	American Association of Psychiatric Pharmacists 2024-02-01
Series:	Mental Health Clinician
Subjects:	stimulant drug interaction monitoring safety pharmacist
Online Access:	https://theijpt.org/doi/pdf/10.9740/mhc.2024.02.017

Similar Items

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024-02-01)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023-10-01)

Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022-04-01)

Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022-11-01)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023-08-01)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)

Survey of prescriptive authority among psychiatric pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, APh, BCPP, FCCP, et al.
Published: (2023-03-01)

The Role of Ambulatory Care Pharmacists in an HIV Multidisciplinary Team within a Free and Bilingual Clinic
by: Ann M. Fugit, Pharm.D., BCPS, et al.
Published: (2013-01-01)

Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023-04-01)

Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)

Patient And phaRmacist Telephonic Encounters (PARTE) in an underserved rural population with asthma: methods and rationale
by: Henry N. Young, PhD, et al.
Published: (2011-01-01)

Medication Adherence Improvements in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Jessica J. Skradski, PharmD, et al.
Published: (2012-01-01)

Lifestyle Medicine-Related Cardiovascular Risk Factor Changes in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Yongyue Qi, et al.
Published: (2012-01-01)

Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit
by: Kimberly A. Redic, PharmD, et al.
Published: (2017-06-01)

Health-Related Quality of Life Impact in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Yongyue Qi, et al.
Published: (2012-01-01)

Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome
by: Beth M. DeJongh, PharmD, BCPP, BCPS
Published: (2021-11-01)

Increasing access to psychiatric care during the COVID-19 pandemic through mental health clinical pharmacy specialist services
by: Vickery P. Brittany PharmD, BCPS, BCPP, CPP, et al.
Published: (2023-08-01)

Impact of Antibiotic Shortage on H. Pylori Treatment: A Step-Wise Approach for Pharmacist Management
by: Ann Lloyd, Pharm.D., BCPS, et al.
Published: (2013-01-01)

Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021-07-01)

Pharmacist Prescriptive Authority for Epinephrine Auto-Injectors in Idaho
by: Alex J Adams, PharmD, MPH
Published: (2016-10-01)

Awareness of and Readiness for Medication Therapy Management Among Community Pharmacists in New York City: Results from a Focus Group
by: Sharrel Pinto, BS Pharm, DMM, MS, PhD, et al.
Published: (2013-01-01)

Project ImPACT: Hypertension Outcomes of a Pharmacist-Provided Hypertension Service
by: Carrie Wentz Nemerovski, PharmD, BCPS, et al.
Published: (2013-01-01)

Assessment of hepatitis C monitoring adherence after viral eradication in veterans with substance use to improve care and surveil reinfection
by: Miranda L. Stratton, PharmD, et al.
Published: (2022-06-01)

Closing the gap: Raising medical professionals' transgender awareness and medical proficiency through pharmacist-led education
by: Ardsley P. Congdon III, PharmD, BCPS, BCPP, et al.
Published: (2021-01-01)

Remember Your MEDS: Medication Education Delivers Success
by: Kelsey M. Rife, PharmD Candidate, et al.
Published: (2012-01-01)

Social Media and Unprofessional Pharmacist Conduct: A Cross-Sectional Survey of Boards of Pharmacy
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Impact on hospital-wide antipsychotic prescribing practices through physician peer comparison letters
by: Erica A. K. Davis, PharmD, BCPS, BCPP
Published: (2022-01-01)

Veteran adherence to oral versus injectable AUD medication treatment
by: Hayden Stewart, PharmD, et al.
Published: (2021-05-01)

Pharmacotherapy treatment of stimulant use disorder
by: Mei T. Liu, PharmD, BCPP
Published: (2021-11-01)

Adverse childhood experiences among California student pharmacists
by: Shawn R. Smith, PharmD, APh, et al.
Published: (2024-02-01)

Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
by: Rachel M. Belcher, PharmD, BCCCP, et al.
Published: (2023-01-01)

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns
by: Danielle Dauchot, PharmD, et al.
Published: (2024-02-01)

Survey of noncontrolled medication misuse patterns
by: Amelia Slane, PharmD, et al.
Published: (2022-06-01)

Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study
by: Nada Alsuhebany BSPharm, PharmD, et al.
Published: (2019-11-01)

Antipsychotic factors related to time to competency for forensic inpatients in a state psychiatric facility
by: Amber Lemons, PharmD, BCPP, et al.
Published: (2022-06-01)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023-03-01)

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022-04-01)